News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Sanofi-Aventis (France) Fails to Block Sale of Generic Cancer Drug Taxotere in Australia
February 2, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Sanofi-Aventis SA failed to block two generic drug manufacturers from selling a copy of the cancer drug Taxotere in Australia, with a federal court judge refusing to bar the sale of the generics.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Sanofi (France)
MORE ON THIS TOPIC
Policy
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
January 12, 2026
·
4 min read
·
Heather McKenzie
Vaccines
Vaccine Investors Keep Their Heads Down as Trump Cuts Shot Schedule
January 6, 2026
·
3 min read
·
Dan Samorodnitsky
Obesity
Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement
January 6, 2026
·
2 min read
·
Tristan Manalac
Drug pricing
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026
January 6, 2026
·
5 min read
·
Annalee Armstrong